Patents by Inventor Bernat Olle

Bernat Olle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190275090
    Abstract: Provided herein are compositions and methods for the treatment or prevention of pathogenic infections.
    Type: Application
    Filed: May 28, 2019
    Publication date: September 12, 2019
    Applicant: Vedanta Biosciences, Inc.
    Inventors: Jessica Schneider, Yun-Gi Kim, Bernat Olle, Shilpa Reddy, Jason Norman, Juan Patarroyo
  • Patent number: 10350250
    Abstract: Provided herein are compositions and methods for the treatment or prevention of pathogenic infections.
    Type: Grant
    Filed: May 30, 2018
    Date of Patent: July 16, 2019
    Assignee: Vedanta Biosciences, Inc.
    Inventors: Jessica Schneider, Yun-Gi Kim, Bernat Olle, Shilpa Reddy, Jason Norman, Juan Patarroyo
  • Publication number: 20190134107
    Abstract: Provided herein are compositions and methods for the treatment of allergy, such as food allergy. Also provided herein are compositions and methods for modulating an immune response associated with allergy and/or inducing immune tolerance or desensitization to an allergy, such as a food allergy.
    Type: Application
    Filed: December 21, 2018
    Publication date: May 9, 2019
    Applicant: Vedanta Biosciences, Inc.
    Inventors: Rose L. Szabady, Bernat Olle, Bruce Roberts
  • Publication number: 20190134179
    Abstract: Compositions consisting of bioactive molecules derived from the microbiota of a mammal are provided herein. When administered orally with a colonic delivery system, the compositions are useful for the prophylaxis and treatment of diseases, in particular inflammatory, autoimmune and infectious diseases. The compositions comprise combinations of small molecules and bacterial antigens formulated in colonic delivery systems. Use of the compositions results in any or all of: induction of immune tolerance; strengthening of the gut mucosal barrier integrity; reduction of inflammation; and amelioration of a disease state caused by inflammation, an autoimmune reaction or an infectious agent.
    Type: Application
    Filed: October 15, 2018
    Publication date: May 9, 2019
    Applicants: Vedanta Biosciences, Inc., Riken
    Inventors: Kenya Honda, Bernat Olle, Koji Atarashi, Takeshi Tanoue, Hiroshi Ohno, Shinji Fukuda, Koji Hase
  • Publication number: 20190030098
    Abstract: Provided herein are compositions and methods for the treatment or prevention of pathogenic infections.
    Type: Application
    Filed: October 11, 2018
    Publication date: January 31, 2019
    Applicant: Vedanta Biosciences, Inc
    Inventors: Jessica Schneider, Yun-Gi Kim, Bernat Olle, Shilpa Reddy, Jason Norman, Juan Patarroyo
  • Patent number: 10130695
    Abstract: Compositions consisting of bioactive molecules derived from the microbiota of a mammal are provided herein. When administered orally with a colonic delivery system, the compositions are useful for the prophylaxis and treatment of diseases, in particular inflammatory, autoimmune and infectious diseases. The compositions comprise combinations of small molecules and bacterial antigens formulated in colonic delivery systems. Use of the compositions results in any or all of: induction of immune tolerance; strengthening of the gut mucosal barrier integrity; reduction of inflammation; and amelioration of a disease state caused by inflammation, an autoimmune reaction or an infectious agent.
    Type: Grant
    Filed: August 18, 2017
    Date of Patent: November 20, 2018
    Assignees: Vedanta Biosciences, Inc., RIKEN
    Inventors: Kenya Honda, Bernat Olle, Koji Atarashi, Takeshi Tanoue, Hiroshi Ohno, Shinji Fukuda, Koji Hase
  • Publication number: 20180264056
    Abstract: Provided herein are compositions and methods for the treatment or prevention of pathogenic infections.
    Type: Application
    Filed: May 30, 2018
    Publication date: September 20, 2018
    Applicant: Vedanta Biosciences, Inc.
    Inventors: Jessica Schneider, Yun-Gi Kim, Bernat Olle, Shilpa Reddy, Jason Norman, Juan Patarroyo
  • Patent number: 10064904
    Abstract: Provided herein are compositions and methods for the treatment or prevention of pathogenic infections.
    Type: Grant
    Filed: January 30, 2018
    Date of Patent: September 4, 2018
    Assignee: Vedanta Biosciences, Inc.
    Inventors: Jessica Schneider, Yun-Gi Kim, Bernat Olle, Shilpa Reddy, Jason Norman, Juan Patarroyo
  • Publication number: 20180169157
    Abstract: Provided herein are compositions and methods for the treatment or prevention of pathogenic infections.
    Type: Application
    Filed: January 30, 2018
    Publication date: June 21, 2018
    Applicant: Vedanta Biosciences, Inc.
    Inventors: Jessica Schneider, Yun-Gi Kim, Bernat Olle, Shilpa Reddy, Jason Norman, Juan Patarroyo
  • Patent number: 9999641
    Abstract: Provided herein are compositions and methods for the treatment or prevention of pathogenic infections.
    Type: Grant
    Filed: June 22, 2017
    Date of Patent: June 19, 2018
    Assignee: Vedanta Biosciences, Inc.
    Inventors: Jessica Schneider, Yun-Gi Kim, Bernat Olle, Shilpa Reddy, Jason Norman, Juan Patarroyo
  • Publication number: 20180000921
    Abstract: Compositions consisting of bioactive molecules derived from the microbiota of a mammal are provided herein. When administered orally with a colonic delivery system, the compositions are useful for the prophylaxis and treatment of diseases, in particular inflammatory, autoimmune and infectious diseases. The compositions comprise combinations of small molecules and bacterial antigens formulated in colonic delivery systems. Use of the compositions results in any or all of: induction of immune tolerance; strengthening of the gut mucosal barrier integrity; reduction of inflammation; and amelioration of a disease state caused by inflammation, an autoimmune reaction or an infectious agent.
    Type: Application
    Filed: August 18, 2017
    Publication date: January 4, 2018
    Applicants: Vedanta Biosciences, Inc., RIKEN
    Inventors: Kenya Honda, Bernat Olle, Koji Atarashi, Takeshi Tanoue, Hiroshi Ohno, Shinji Fukuda, Koji Hase
  • Publication number: 20170354697
    Abstract: Provided herein are compositions and methods for the treatment or prevention of pathogenic infections.
    Type: Application
    Filed: June 22, 2017
    Publication date: December 14, 2017
    Applicant: Vedanta Biosciences, Inc.
    Inventors: Jessica Schneider, Yun-Gi Kim, Bernat Olle, Shilpa Reddy, Jason Norman, Juan Patarroyo
  • Patent number: 9764019
    Abstract: Compositions consisting of bioactive molecules derived from the microbiota of a mammal are provided herein. When administered orally with a colonic delivery system, the compositions are useful for the prophylaxis and treatment of diseases, in particular inflammatory, autoimmune and infectious diseases. The compositions comprise combinations of small molecules and bacterial antigens formulated in colonic delivery systems. Use of the compositions results in any or all of: induction of immune tolerance; strengthening of the gut mucosal barrier integrity; reduction of inflammation; and amelioration of a disease state caused by inflammation, an autoimmune reaction or an infectious agent.
    Type: Grant
    Filed: July 8, 2014
    Date of Patent: September 19, 2017
    Assignees: Vedanta Biosciences, Inc., RIKEN
    Inventors: Kenya Honda, Bernat Olle, Koji Atarashi, Takeshi Tanoue, Hiroshi Ohno, Shinji Fukuda, Koji Hase
  • Publication number: 20160144014
    Abstract: Compositions consisting of bioactive molecules derived from the microbiota of a mammal are provided herein. When administered orally with a colonic delivery system, the compositions are useful for the prophylaxis and treatment of diseases, in particular inflammatory, autoimmune and infectious diseases. The compositions comprise combinations of small molecules and bacterial antigens formulated in colonic delivery systems. Use of the compositions results in any or all of: induction of immune tolerance; strengthening of the gut mucosal barrier integrity; reduction of inflammation; and amelioration of a disease state caused by inflammation, an autoimmune reaction or an infectious agent.
    Type: Application
    Filed: July 8, 2014
    Publication date: May 26, 2016
    Applicants: VEDANTA BIOSCIENCES, RIKEN
    Inventors: Kenya Honda, Bernat Olle, Koji Atarashi, Takeshi Tanoue, Hiroshi Ohno, Shinji Fukuda, Koji Hase
  • Publication number: 20120149584
    Abstract: Methods of diagnosing and treating microbiome-associated disease or improving health using interaction network parameters are provided. Methods are provided to analyze interaction networks between microbes, and between microbes and the host, to determine important (e.g. “highly-connected”) organisms or molecules as determined by various network parameters. Methods are provided including and beyond correlation to use these “highly-connected” organisms or molecules as targets for modulation or as therapeutic agents to improve health.
    Type: Application
    Filed: August 20, 2010
    Publication date: June 14, 2012
    Inventors: Bernat Olle, Jonathan Robert Behr, W. Edward Martucci, Daphne Zohar
  • Publication number: 20100298760
    Abstract: The invention features methods, kits, and compositions for administering pharmaceutical compounds using microdermabrasion particles.
    Type: Application
    Filed: October 21, 2008
    Publication date: November 25, 2010
    Inventors: Bernat Olle, Daphne Zohar, Jonathan Behr, David Steinberg
  • Patent number: 7208134
    Abstract: One aspect of the present invention relates to magnetic nanoparticles colloidally stabilized in aqueous milieu by association with an organic phase. The organic phase may be either a fluorinated polymer or an organic hydrocarbon bilayer, wherein the two layers are chemically bonded to each other. The stabilized particles are further non-toxic and provide useful enhancements in bioprocesses. Another aspect of the present invention relates to compositions comprising an oxygen-dissolving fluid vehicle and surface modified, nanometer-sized magnetic particles. The inventive compositions have utility in a wide range of applications, but are particularly suitable for use as recyclable oxygen carriers, separation and purification vehicles, and bioprocessing media, including fermentation processes.
    Type: Grant
    Filed: December 20, 2004
    Date of Patent: April 24, 2007
    Assignee: Massachusetts Institute of Technology
    Inventors: Lev E. Bromberg, T. Alan Hatton, Daniel I. C. Wang, Jin Yin, Bernat Olle
  • Publication number: 20060040388
    Abstract: One aspect of the present invention relates to magnetic nanoparticles colloidally stabilized in aqueous milieu by association with an organic phase. The organic phase may be either a fluorinated polymer or an organic hydrocarbon bilayer, wherein the two layers are chemically bonded to each other. The stabilized particles are further non-toxic and provide useful enhancements in bioprocesses. Another aspect of the present invention relates to compositions comprising an oxygen-dissolving fluid vehicle and surface modified, nanometer-sized magnetic particles. The inventive compositions have utility in a wide range of applications, but are particularly suitable for use as recyclable oxygen carriers, separation and purification vehicles, and bioprocessing media, including fermentation processes.
    Type: Application
    Filed: December 20, 2004
    Publication date: February 23, 2006
    Inventors: Lev Bromberg, T. Hatton, I. Wang, Jin Yin, Bernat Olle